PROFHILO® H+L by IBSA is an injectable hyaluronic acid product for professional use. Its formulation combines high- and low-molecular-weight hyaluronic acid in stabilised hybrid complexes and contains a total of 64 mg of hyaluronic acid in 2 ml.
PROFHILO® H+L is used for bio-remodelling and differs in its concept and product characteristics from conventional volumising hyaluronic acid fillers.
Pack contents:
1 × 2 ml pre-filled syringe
2 × 29G × 1/2" needles
PROFHILO® H+L 2 ml by IBSA is an injectable hyaluronic-acid medical device for professional aesthetic use. One pack contains one 2 ml prefilled syringe with a total of 64 mg hyaluronic acid – 32 mg high-molecular-weight H-HA and 32 mg low-molecular-weight L-HA – plus two 29G × 13 mm needles.
The stabilised Hybrid Cooperative Complexes are produced using patented NAHYCO® Hybrid Technology without BDDE as a chemical cross-linking agent. PROFHILO® H+L is designed as a bio-remodelling product and therefore differs from classic dermal fillers whose main purpose is targeted volume augmentation or contour projection.
PROFHILO® H+L is a sterile hyaluronic-acid medical device from IBSA. The formulation contains 32 mg high-molecular-weight and 32 mg low-molecular-weight hyaluronic acid in a 2 ml prefilled syringe.
Unlike classic chemically cross-linked hyaluronic-acid fillers, stabilisation is achieved by a patented thermal manufacturing process. The two hyaluronic-acid fractions are combined into stabilised cooperative hybrid complexes. BDDE is not used for this process.
NAHYCO® Hybrid Technology combines high- and low-molecular-weight hyaluronic acid through a controlled thermal process.
IBSA Germany lists the face, neck, décolleté and hands among the areas for PROFHILO® H+L. Suitability in an individual case depends on the current instructions for use, the individual assessment and the professional decision of the qualified practitioner.
PROFHILO® is frequently used with the BAP technique – Bio Aesthetic Points. The original documents show the product-specific point scheme for the face and neck.
These documents do not replace the current instructions for use or professional training. Anatomy, patient selection, injection depth and the specific procedure remain the responsibility of qualified healthcare professionals.
PROFHILO® H+L is a medical device under Regulation (EU) 2017/745 (MDR). Application, patient selection and treatment planning belong in the hands of appropriately qualified professionals.
The current manufacturer instructions for use are authoritative for indications, contraindications, warnings, adverse effects, application technique and traceability.
Applicable legal requirements for the purchase, storage, documentation and use of medical devices must be observed.
One 2 ml prefilled syringe contains a total of 64 mg hyaluronic acid: 32 mg high-molecular-weight hyaluronic acid (H-HA) and 32 mg low-molecular-weight hyaluronic acid (L-HA).
One pack contains one prefilled syringe with 2 ml PROFHILO® H+L plus two 29G × 13 mm needles.
No. IBSA describes PROFHILO® as thermally stabilised hyaluronic acid based on NAHYCO® Hybrid Technology. The manufacturing process does not use BDDE as a chemical cross-linking reagent.
IBSA positions PROFHILO® H+L as a bio-remodelling product. Its objective therefore differs from classic fillers, where targeted volume augmentation or contour projection is typically the main focus.
According to current IBSA Germany information, the pack contains one 2 ml prefilled syringe and two 29G × 13 mm needles.
The PDF guides for face and neck are linked directly above. The current manufacturer instructions for use remain authoritative for application.
In addition to PROFHILO® H+L, professional users can find further products from the PROFHILO® family at prpmed.de. Background information on IBSA, the product family and the classification of the individual PROFHILO® products is available on the IBSA brand page.
PROFHILO® is a product line from IBSA Derma. At its core is NAHYCO® Hybrid Technology, developed by IBSA, in which hyaluronic acid with different molecular weights is processed through a controlled thermal process to form cooperative hybrid complexes. Today, the brand includes several independent product concepts for professional aesthetic medicine.
The name PROFHILO® is often associated directly with PROFHILO® H+L. For correct classification, however, it is important to note that PROFHILO® now refers to a product family. Within this line, IBSA Derma develops different concepts for different areas of professional use.
PROFHILO® H+L, PROFHILO® BODY and PROFHILO® STRUCTURA belong to the same brand family, but they are not interchangeable versions of the same product. Composition, pack contents, intended use and application are always determined by the specific product and its current instructions for use.
In 2015, IBSA patented a thermal manufacturing process that combines high- and low-molecular-weight hyaluronic acid. This produces so-called cooperative hybrid complexes.
The technological approach used to form these hybrid complexes does not require chemical cross-linking reagents. NAHYCO® therefore provides a shared technological framework within the PROFHILO® family, without implying identical product properties for every variant.
Three product concepts under one brand. For specific technical data and professional-use information, each area links directly to the relevant product page.
The established PROFHILO® product for professional bio-remodelling. Detailed information on contents, hyaluronic acid amount, needles and product-specific use is provided only on the product page.
View PROFHILO® H+LThe PROFHILO® line for professional application concepts on the body. At prpmed.de, the concept is available as a Body Kit combining an injectable component with complementary care products.
View PROFHILO® BODYAn independent product within the PROFHILO® family with a different formulation and application concept from H+L. Technical information is therefore presented separately.
View PROFHILO® STRUCTURAThe injectable products in the PROFHILO® family are intended for professional use. Which product may be appropriate for a specific application cannot be inferred from the brand name alone. The intended purpose, current instructions for use, professional qualifications and the practitioner’s individual assessment are decisive.
For this reason, prpmed.de presents the individual PROFHILO® products separately, with their respective product data and availability.
PROFHILO® is part of the IBSA Derma portfolio. IBSA develops and manufactures, among other things, hyaluronic-acid-based products for medical and dermo-aesthetic applications.
No. PROFHILO® is a product family. At prpmed.de, PROFHILO® H+L, PROFHILO® BODY and PROFHILO® STRUCTURA are among the products listed or presented.
NAHYCO® refers to a technology developed by IBSA and patented in 2015, in which hyaluronic acid with different molecular weights is processed through a controlled thermal process to form cooperative hybrid complexes.
No. Both belong to the PROFHILO® family, but they are independent products. Formulation, pack contents, intended purpose and application must be considered on a product-specific basis.
Specific information is provided on the relevant product page and in the current manufacturer instructions for use. The brand page is intended to classify the product family and does not replace product-specific documentation.
IBSA Institut Biochimique SARegistered Office
Via Pian Scairolo 49
CH-6912 Lugano-Pazzallo
Management and Offices
Via del Piano 29
CH-6926 Collina d’Oro-Montagnola+41 58 360 10 00
https://www.ibsagroup.com/contact.html
